What is the current BRN.AX stock price and market cap?

BRN.AX stock closed at A$0.175 on 21 Jan 2026 with a market cap of A$412.73M and volume of 5,730,873 shares, signalling modest liquidity relative to its 3‑month average.

What price target does Meyka AI give for BRN.AX?

Meyka AI's 12‑month forecast for BRN.AX is A$0.190, implying an upside of about 8.79% from the closing price of A$0.175. Forecasts are model-based and not guarantees.

When is BrainChip’s next earnings release and why it matters?

BrainChip’s earnings announcement is scheduled for 04 Mar 2026. Results and guidance could shift sentiment if Akida sales or partner wins show clearer revenue growth or margin improvement.

What are main risks to owning BRN.AX on ASX?

Principal risks include continued operating losses, high valuation multiples relative to revenues, low liquidity, and competition in AI semiconductors. Positive design wins are required to de-risk the story.

AU Stocks

BRN.AX BrainChip (ASX) closes A$0.175 on 21 Jan 2026: Akida progress shapes AI chip outlook

ByHuzaifa Zahoor January 21, 2026January 21, 2026

BRN.AX stock closed the ASX session at A$0.175 on 21 Jan 2026, down 2.78% as traders digested limited volume of 5,730,873 shares. BrainChip Holdings Ltd (BRN.AX) remains an AI edge hardware play, driven by its Akida neuromorphic processor and development tools. We track valuation stress, negative EPS of -0.02, and short-term technical overbought signals while weighing a model forecast that points to modest upside versus current price.